Livongo Joins JDRF Ride to Cure Diabetes® to Support Type 1 Diabetes
― Livongo raises more than $319,000 for type 1 diabetes research ―
New York, August, 13, 2019 ― On August 10, JDRF kicked off the 2019 La Crosse, Wisconsin, Ride to Cure Diabetes to help fund critically needed type 1 diabetes (T1D) research. The charitable bike ride attracted more than 660 riders, including 136 Livongo employees, friends, and family who this year raised $319,000 through individual fundraising and corporate sponsorship toward JDRF’s mission to accelerate life-changing breakthroughs to cure, prevent and treat T1D and its complications.
The La Crosse Ride is one of five nationwide JDRF Ride to Cure Diabetes events that bring together people of all ages and experience levels in support of a world without T1D. Livongo’s participation in the JDRF Ride to Cure Diabetes dates back to 2016.
“At Livongo, we dedicate ourselves to transforming the healthcare experience for people with diabetes. This cause is very personal to us because many of our employees also live with a chronic condition,” said Livongo President Dr. Jennifer Schneider M.D., M.S. “The annual JDRF Ride is a wonderful opportunity for Livongo to connect as a team, with the community, our families, and challenge similar organizations to give back in a big way.”
In just four years, Livongo’s support of JDRF, the leading global organization funding T1D research, has raised more than $569,000. This year Team Livongo increased their rider participation by 35 percent, with 150 riders partaking in the La Crosse, WI, Sonoma, CA and Saratoga Springs, NY rides.
“We are excited at how our relationship with Livongo continues to grow,” said Aaron J. Kowalski, JDRF President, and CEO. “Partners like Livongo, in conjunction with our many volunteers, are the backbone of our organization. Their commitment is helping to galvanize the impact JDRF is making every day in the lives of people living with T1D.”
In recognition of Livongo’s continued commitment to the JDRF mission and Ride to Cure Diabetes event, they were awarded the Top Recruiter Awards, with Top Recruiter Jerseys given to three participants, Ashley Beresid, Elizabeth Sayed, and Chris Mack.
“Year after year, JDRF Ride participants return to champion for a common cause,” said Alyson Levine, JDRF National Director, Ride to Cure. “We are extremely grateful for the thousands of riders, sponsors, and donors from across the country. Every dollar raised helps fund research that brings us one step closer to finding a cure.”
To date, JDRF Ride to Cure Diabetes has raised more than $47 million for T1D research. Each rider commits to raising a minimum dollar amount, starting at $2,000. To learn more, visit ride.jdrf.org.
Type 1 diabetes (T1D) is an autoimmune disease in which a person’s pancreas stops producing insulin, a hormone that enables people to get energy from food. It occurs when the body’s immune system attacks and destroys the insulin-producing cells in the pancreas, called beta cells. While its causes are not yet entirely understood, scientists believe that both genetic factors and environmental triggers are involved. Its onset has nothing to do with diet or lifestyle. There is nothing you can do to prevent T1D, and—at present—nothing you can do to get rid of it.
JDRF is the leading global organization funding type 1 diabetes (T1D) research. Our mission is to accelerate life-changing breakthroughs to cure, prevent and treat T1D and its complications. To accomplish this, JDRF has invested more than $2.2 billion in research funding since our inception. We are an organization built on a grassroots model of people connecting in their local communities, collaborating regionally for efficiency and broader fundraising impact, and uniting on a national stage to pool resources, passion, and energy. We collaborate with academic institutions, policymakers, and corporate and industry partners to develop and deliver a pipeline of innovative therapies to people living with T1D. Our staff and volunteers throughout the United States and our six international affiliates are dedicated to advocacy, community engagement and our vision of a world without T1D. For more information, please visit jdrf.org or follow us on Twitter: @JDRF